C-MYC-induced apoptosis in polycystic kidney disease is Bcl-2 and p53 independent

被引:86
|
作者
Trudel, M [1 ]
Lanoix, J [1 ]
Barisoni, L [1 ]
Blouin, MJ [1 ]
Desforges, M [1 ]
LItalien, C [1 ]
DAgati, V [1 ]
机构
[1] COLUMBIA UNIV COLL PHYS & SURG, DEPT PATHOL, NEW YORK, NY 10032 USA
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 1997年 / 186卷 / 11期
关键词
D O I
10.1084/jem.186.11.1873
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The SBM mouse is a unique transgenic model of polycystic kidney disease (PKD) induced by the dysregulated expression of c-myc in renal tissue. In situ hybridization analysis demonstrated intense signal for the c-myc transgene overlying tubular cystic epithelium in SBM mice. Renal proliferation index in SBM kidneys was 10-fold increased over nontransgenic controls correlating with the presence of epithelial hyperplasia. The specificity of c-myc for the proliferative potential of epithelial cells was demonstrated by substitution of c-myc with the proto-oncogene c-fos or the transforming growth factor (TGF)-alpha within the same construct. No renal abnormalities were detected in 13 transgenic lines established, indicating that the PKD phenotype is dependent on functions specific to c-myc. We also investigated another well characterized function of c-myc, the regulation of apoptosis through pathways involving p53 and members of the bcl-2 family, which induce and inhibit apoptosis, respectively. The SBM kidney tissues, which overexpress c-myc, displayed a markedly elevated (10-100-fold) apoptotic index. However, no significant difference in bcl-2, bax, or p53 expression was observed in SBM kidney compared with controls. Direct proof that the heightened renal cellular apoptosis in PKD is not occurring through p53 was obtained by successive matings between SBM and p53(-/-) mice. All SBM offspring, irrespective of their p53 genotype, developed PKD with increased renal epithelial apoptotic index. In addition, overexpression of both bcl-2 and c-myc in double transgenic mice (SBB+/SBM+) also produced a similar PKD phenotype with a high apoptotic rate, showing that c-myc can bypass bcl-2 in vivo. Thus, the in vivo c-myc apoptotic pathway in SBM mice occurs through a p53- and bcl-2-independent mechanism. We conclude that the pathogenesis of PKD is c-myc specific and involves a critical imbalance between the opposing processes of cell proliferation and apoptosis.
引用
收藏
页码:1873 / 1884
页数:12
相关论文
共 50 条
  • [21] bcl-2 expression, p53 accumulation, and apoptosis in ovarian carcinomas
    Diebold, J
    Baretton, G
    Felchner, M
    Meier, W
    Dopfer, K
    Schmidt, M
    Lohrs, U
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1996, 105 (03) : 341 - 349
  • [22] Expression of apoptosis regulating proteins p53 and bcl-2 in psoriasis
    Moorchung, Nikhil
    Vasudevan, Biju
    Kumar, Dinesh S.
    Muralidhar, Archit
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2015, 58 (04) : 423 - 426
  • [23] Apoptosis in thyroid neoplasms: relationship with p53 and bcl-2 expression
    Moore, D
    Ohene-Fianko, D
    Garcia, B
    Chakrabarti, S
    HISTOPATHOLOGY, 1998, 32 (01) : 35 - 42
  • [24] Signaling through the antigen receptor of B lymphocytes activates a p53-independent pathway of c-Myc-induced apoptosis
    Hiroyuki Hagiyama
    Takahiro Adachi
    Tsutomu Yoshida
    Takashi Nomura
    Nobuyuki Miyasaka
    Tasuku Honjo
    Takeshi Tsubata
    Oncogene, 1999, 18 : 4091 - 4098
  • [25] Signaling through the antigen receptor of B lymphocytes activates a p53-independent pathway of c-Myc-induced apoptosis
    Hagiyama, H
    Adachi, T
    Yoshida, T
    Nomura, T
    Miyasaka, N
    Honjo, T
    Tsubata, T
    ONCOGENE, 1999, 18 (28) : 4091 - 4098
  • [26] Structures of p53/BCL-2 complex suggest a mechanism for p53 to antagonize BCL-2 activity
    Wei, Hudie
    Wang, Haolan
    Wang, Genxin
    Qu, Lingzhi
    Jiang, Longying
    Dai, Shuyan
    Chen, Xiaojuan
    Zhang, Ye
    Chen, Zhuchu
    Li, Youjun
    Guo, Ming
    Chen, Yongheng
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [27] ALTERATIONS OF THE BCL-2, C-MYC AND P53 GENES IN DIFFUSE LARGE CELL LYMPHOMAS
    FARRUGIA, M
    DUAN, LJ
    BERINSTEIN, N
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 265 - 265
  • [28] p53, Bcl-2 and C-Myc expressions in colorectal carcinoma associated with schistosomiasis in Egypt
    Zalata, KR
    Nasif, WA
    Ming, SC
    Lotfy, M
    Nada, NA
    El-Hak, NG
    Leech, SH
    CELLULAR ONCOLOGY, 2005, 27 (04) : 245 - 253
  • [29] c-MYC-Induced Sebaceous Gland Differentiation Is Controlled by an Androgen Receptor/p53 Axis
    Cottle, Denny L.
    Kretzschmar, Kai
    Schweiger, Pawel J.
    Quist, Sven R.
    Gollnick, Harald P.
    Natsuga, Ken
    Aoyagi, Satoru
    Watt, Fiona M.
    CELL REPORTS, 2013, 3 (02): : 427 - 441
  • [30] Cell proliferation, bcl-2, c-myc, p53 and apoptosis as indicators of different aggressiveness in small lymphocytic lymphoma (SLL)
    Palestro, G
    Ponti, R
    Chiusa, L
    Chiarle, R
    Geuna, M
    Novero, D
    Freilone, R
    Pich, A
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1997, 59 (03) : 148 - 154